|Bid price||1,818.00||Open price||1,837.00|
|Ask price||1,824.00||Prev close||1,821.00|
Register now for FREE live Hikma Pharmaceuticals share prices, Hikma Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Hikma Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Hikma Pharmaceuticals (HIK) and other London Stock Exchange equities.
Register now for FREE Hikma Pharmaceuticals share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB00B0LCW083|
|Activites||Hima Pharmaceuticals plc is a multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products.||Index||FTSE 100|
|Latest Share Price (p)||1,821.00||Net Gearing (%)||41.19|
|Market Capitalisation (£m)||4,427.61||Gross Gearing (%)||44.74|
|Shares in issue (m)||239.98||Debt Ratio||30.02|
|P/E Ratio||27.74||Debt-to-Equity Ratio||0.53|
|Total dividends per share (p)||33.00||Assets / Equity Ratio||1.81|
|Dividend Yield (%)||1.15||Price to book value||1.84|
|Dividend cover (x)||3.19||ROCE (%)||6.10|
|Earning per share (p)||66.50||EPS Growth (%)||-47.47|
|52 week high / low||2,703.00 / 1,575.00||DPS Growth (%)||3.13|
|Dec.Date||Type||Director||Pos||No. of Shares|
RNS Number : 4403C Hikma Pharmaceuticals Plc 13 April 2017 Notification and public disclosure of transactions by persons discharging managerial responsibilities 1 Details of the person discharging managerial responsibilities / person closely associated...
RNS Number : 4388C Hikma Pharmaceuticals Plc 13 April 2017 Hikma Pharmaceuticals PLC - EIP Awards LONDON, 13 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the Remuneration Committee has made the following conditional...
RNS Number : 4387C Hikma Pharmaceuticals Plc 13 April 2017 Hikma Pharmaceuticals PLC - EIP Awards LONDON, 13 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the Remuneration Committee has made the following conditional...
Register now for FREE Hikma Pharmaceuticals company news
Floated in London last November at 290p (FTSE-250). Company website www.hikma.com Develops, manufactures and markets branded and non-branded generic pharmaceuticals, as well as in-licensed, patented pharmaceuticals Geographic markets: USA, Europe and the Middle East & North Africa...
Register now for FREE Hikma Pharmaceuticals share price discussions